Evidence map›Paper›PMID 41264585›Full record

ArticlePloS one2025

Concern for severe COVID-19 disease during the initial two years of pandemic in a rural South African community: A population-based study.

Armstrong Dzomba, Palesa Mataboge, Nicole K Kelly, Kelechi Elizabeth Oladimeji, Carren Ginsburg, Bianca Moffett, Chodziwadziwa Kabudula, Kimberley Gutu, Audrey Pettifor, Francesc Xavier Gómez-Olivé and 1 more

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Armstrong DzombaSchool of Nursing, Psychotherapy and Community Health, Dublin City University, Glasnevin Campus, Dublin, Ireland.ORCID https://orcid.org/0000-0002-4242-6312
Palesa MatabogeSchool of Built Environment and Development Studies, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa.
Nicole K KellyDepartment of Epidemiology, University of North Carolina, Gillings School of Global Public Health, Chapel Hill, North Carolina, United States of America.ORCID https://orcid.org/0000-0003-1061-2767
Kelechi Elizabeth OladimejiEzintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Carren GinsburgMedical Research Council/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, Gauteng, South Africa.
Bianca MoffettMedical Research Council/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, Gauteng, South Africa.
Chodziwadziwa KabudulaMedical Research Council/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, Gauteng, South Africa.
Kimberley GutuSouth African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, Gauteng, South Africa.
Audrey PettiforDepartment of Epidemiology, University of North Carolina, Gillings School of Global Public Health, Chapel Hill, North Carolina, United States of America.
Francesc Xavier Gómez-OlivéMedical Research Council/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, Gauteng, South Africa.
Kathleen KahnMedical Research Council/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, Gauteng, South Africa.

Funding

Training in Infectious Disease Epidemiology (TIDE)T32AI070114 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Brian W Pence · 2007 to 2026
$4.0M
NIAID NIH HHS T32 AI070114
6 · The paper itself

Abstract

backgroundGlobally, as of December 2023, over 700 million cases of COVID-19 were confirmed since the initial outbreak late in 2019, claiming around 7 million lives and fuelling widespread fear and anxiety. However, prospective patient-data are unavailable to assess individuals' perceptions of risk of severe COVID-19 illness, which may imply actual disease severity and inform risk perception for future epidemics.

methodsWe surveyed 1701 adults about their concern for severe COVID-19 disease using a population-based survey of rural South Africans. The initial telephonic survey was conducted between August-October 2020 with a follow-up survey conducted between August-October 2021. Multinomial logistic regression was used to investigate predictors of perceived COVID-19 illness severity (low, medium, or high) controlling for measured confounders.

resultsThe prevalence of concern for COVID-19 illness severity in 2020 was 28.7% low, 26.8% moderate and 44.5% severe, with corresponding levels in 2021 of 42%, 31.8% and 29.2%, respectively. Although older age was associated with a lower odds of COVID-19 concern [50-59 years (aOR=0.54, 95% CI: 0.38-0.75)], [≥60 years (aOR=0.41,95% CI: 0.41-0.57)], adults having ≥1 chronic conditions (aOR=1.38,1.00-1.89) or residing outside of the study community (aOR=1.29,1.01-1.65) were more likely to experience moderate and high concern for illness severity, respectively.

conclusionsUnderstanding presumptive COVID-19 disease severity may help disentangle various underlying mechanisms behind personal risk assessment. This may inform current thinking and practice of public health emergency medicine in managing emerging and re-emerging respiratory diseases with pandemic potential such as hPMV.

Indexed as

COVID-19AdolescentAdultAgedFemaleHumansMaleMiddle AgedPandemicsRural PopulationSARS-CoV-2Severity of Illness IndexSouth AfricaSurveys and QuestionnairesYoung Adult

Identifiers

PMID41264585
PMCPMC12633895

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.